Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine
This study has been completed.
Study NCT00505453   Information provided by GlaxoSmithKline

First Received on July 20, 2007.   Last Updated on October 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial